OncoSnacks Ep 4: Immune-Mediated Pneumonitis

This episode of OncoSnacks kicks off Michael and Josh's sojourn into the wide world of immune-mediated adverse effects. Inevitably, as most blowhards do, they begin with the lungs. Immune-mediated pneumonitis is not as common as endocrine-axis abnormalities, dermatitis or colitis, but it can be insidious and devastating in equal measure. Such is the potential impact that must be considered in any patient who has received immunotherapy who presents with dyspnoea or a dry cough. Listen on to find out more, and you will also learn what irAEs and Senator Joseph McCarthy have in common.

Guidelines for the management of Pneumonitis are available at:

https://www.frontiersin.org/articles/10.3389/fonc.2020.01785/full#:~:text=will%20be%20discussed.-,Incidence%20and%20Risk%20Factors,due%20to%20pneumonitis%20(6)

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161534/

https://www.eviq.org.au/clinical-resources/side-effect-and-toxicity-management/immunological/1993-management-of-immune-related-adverse-events